| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.2 | 3e-05 |